Paraoxonase 1 (PON1) is present in postprandial chylomicrons
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 180 (1) , 55-61
- https://doi.org/10.1016/j.atherosclerosis.2004.12.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Paraoxonase gene polymorphisms, oxidative stress, and diseasesJournal of Molecular Medicine, 2003
- Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout miceFree Radical Biology & Medicine, 2003
- Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic LesionsCirculation, 2000
- Human Serum Paraoxonase/Arylesterase’s Retained Hydrophobic N -Terminal Leader Sequence Associates With HDLs by Binding PhospholipidsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.Journal of Clinical Investigation, 1998
- Structural and functional diversity of paraoxonasesNature Medicine, 1996
- Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteinsCurrent Opinion in Lipidology, 1996
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.Journal of Clinical Investigation, 1995
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993
- Studies on human serum paraoxonase/arylesteraseChemico-Biological Interactions, 1993